The ERK5 pathway in BRAFV600E melanoma cells plays a role in development of acquired resistance to dabrafenib but not vemurafenib
Mondru, Anil Kumar, Wilkinson, Beth, Aljasir, Mohammad A., Alrumayh, Ahmed, Greaves, Georgia, Emmett, Maxine, Albohairi, Saad, Pritchard‐Jones, Rowan, Cross, Michael J.
Published in FEBS letters (01.08.2024)
Published in FEBS letters (01.08.2024)
Get full text
Journal Article